NEXALIN TECHNOLOGY INC (NXL)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$5.06-5.60%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · NXL
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 0.2 | 0.3 | 0.2 | 0.1 | 1.3 | 0.1 | — |
| Total Revenues | 0.2 | 0.3 | 0.2 | 0.1 | 1.3 | 0.1 | — |
| Cost of Revenues | 0.0 | 0.1 | 0.0 | 0.0 | 0.4 | 0.0 | — |
| Gross Profit | 0.2 | 0.2 | 0.1 | 0.1 | 1.0 | 0.1 | — |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 4.2 | 4.4 | 4.2 | 1.9 | 1.5 | 5.2 | — |
| R&D Expenses | 1.4 | 1.1 | 1.2 | 1.9 | 0.5 | 0.1 | 1.5 |
| Operating Income | (9.1) | (8.4) | (7.8) | (5.7) | (1.8) | (6.0) | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | (0.0) | (0.0) | (0.0) | 0.0 | 0.1 | 0.1 | — |
| Other Non-Operating Income / Expenses | 0.1 | 0.2 | 0.1 | 1.0 | 0.1 | (0.1) | — |
| EBT, Incl. Unusual Items | (9.0) | (8.2) | (7.6) | (4.6) | — | — | — |
| Net Income | |||||||
| Net Income | (9.0) | (8.2) | (7.6) | (4.6) | (1.7) | (6.1) | — |
| Per Share | |||||||
| Basic EPS | (0.43) | (0.50) | (0.83) | (0.63) | (0.30) | — | — |
| Diluted EPS | (0.43) | (0.50) | (0.83) | (0.63) | (0.30) | — | — |
| Revenue per Share | 0.01 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 21.1 | 16.4 | 9.2 | 7.4 | 5.6 | — | — |
| Diluted Weighted Avg Shares | 21.1 | 16.4 | 9.2 | 7.4 | 5.6 | — | — |
| Supplemental | |||||||
| EBIT | (9.1) | (8.4) | (7.8) | (5.7) | (1.8) | (6.0) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.